High Dose Rate Electronic Radiation Skin Cancer Treatment Now Available in US

California Skin Institute founder Greg S. Morganroth, M.D., announced today the addition of electronic brachytherapy (eBx) to the skin cancer treatment options provided by Silicon Valley’s largest dermatology practice. This new treatment technique, a cutting-edge development allowing for extremely conformal, focused, high-dose radiation to be administered to isolated areas, completes the full spectrum of skin cancer treatments offered by California Skin Institute and their team of dermatologists, Mohs surgeons, radiation oncologists, dermatopathologists, and plastic surgeons.

Traditional options for skin cancer treatment are categorized as surgical (traditional excision and Mohs Surgery) and non-surgical (topical drugs and radiation therapy). Localized radiation treatment provides high cure rates, pain-free treatment, and excellent cosmetic results in tandem with a long-proven history of successful use.

The electronic brachytherapy now administered by California Skin Institute is a state-of-the-art alternative to more traditional radiation therapies found in hospital settings. California Skin Institute’s radiation technologists and board-certified radiation oncologists utilize a miniaturized x-ray source to deliver accurate, high-dose radiation to skin cancer cells while sparing the surrounding normal tissue. These treatments take place in the properly equipped office setting of California Skin Institute clinics for patient convenience. The non-invasive eBx treatments at California Skin Institute are painless and require no surgery and no stitches. Electronic brachytherapy has a cure rate up to 97.5%, approaching the cure rate of Mohs Surgery but without the risks of infection, anatomical distortion, or scarring.

For more information about electronic brachytherapy at California Skin Institute, call 408.369.5600 to speak with Dr. Bob Sinha, lead Radiation Oncologist, or Dr. Greg Morganroth or visit www.CAskin.com. California Skin Institute is a medical corporation founded by Greg S. Morganroth, MD.